LRRK2 and inflammatory bowel disease: The link of LRRK2 to innate immune inflammatory pathways is further strengthened by findings that LRRK2 polymorphisms also enhance the risk of developing inflammatory bowel disease (Barrett et al., 2008; Franke et al., 2010).